Two Sigma Advisers’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,732
Closed -$83.3K 2654
2022
Q4
$83.3K Sell
4,732
-2,322
-33% -$44.7K ﹤0.01% 2315
2022
Q3
$155K Sell
7,054
-1,709
-20% -$48K ﹤0.01% 2250
2022
Q2
$210K Buy
8,763
+5,716
+188% +$209K ﹤0.01% 2259
2022
Q1
$201K Buy
3,047
+960
+46% +$75.4K ﹤0.01% 2379
2021
Q4
$220K Buy
2,087
+1,713
+458% +$267K ﹤0.01% 2253
2021
Q3
$68K Buy
+374
New +$77.6K ﹤0.01% 2350
2021
Q2
Sell
-60
Closed -$16K 2558
2021
Q1
$16K Buy
+60
New +$20.2K ﹤0.01% 2523
2020
Q4
Sell
-1,994
Closed -$286K 2485
2020
Q3
$286K Buy
1,994
+1,927
+2,876% +$487K ﹤0.01% 2026
2020
Q2
$49K Buy
+67
New +$29.1K ﹤0.01% 2424

Other funds holding IMNN

Two Sigma Advisers's IMNN Position: Q1 2023 in Review

Two Sigma Advisers sold out of Imunon (IMNN) in Q1 2023, closing a stake of 4,732 shares — an estimated $83.3K sold.

Two Sigma Advisers first reported a position in IMNN in Q2 2020 and held it in 9 quarters. The position peaked at $286K in Q3 2020. 18 funds tracked by Wall St. Rank hold IMNN as of Q1 2023.

  • Two Sigma Advisers reported no remaining Imunon position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 4,732 Imunon shares in Q1 2023, an estimated $83.3K.
  • Two Sigma Advisers first reported a position in Imunon in Q2 2020 and held it in 9 quarters.
  • Two Sigma Advisers's Imunon position peaked at $286K in Q3 2020.
  • 18 funds tracked by Wall St. Rank held Imunon as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.